About
Contact & Profiles
A5064881266
Research Areas
- HER2/EGFR in Cancer Research
- Monoclonal and Polyclonal Antibodies Research
- Lung Cancer Treatments and Mutations
- Cell Adhesion Molecules Research
- Glycosylation and Glycoproteins Research
- Fibroblast Growth Factor Research
- Lymphoma Diagnosis and Treatment
- Angiogenesis and VEGF in Cancer
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
10.1007/s10549-015-3503-3
article
EN
Breast Cancer Research and Treatment
2015-08-01
10.1007/s11523-018-0616-8
article
EN
Targeted Oncology
2019-01-11
10.1016/j.intimp.2018.06.034
article
EN
International Immunopharmacology
2018-07-23
10.1007/s00280-019-03848-9
article
EN
Cancer Chemotherapy and Pharmacology
2019-04-29
Vascular endothelial growth factor (VEGF) and fibroblast growthfactor (FGF) play important roles in angiogenesis-related diseases. RC28-E is a soluble fusion protein composed of the human VEGF receptor 1 (VEGFR1) extracellular domain 2 (ECD 2), VEGFR2 ECD 3, FGFR1 ECDs Fc regions immunoglobulin G1. By targeting both FGF2, may represent useful antiangiogenetic agent, but structural functional characterizations this are needed. Liquid chromatography–tandem mass spectrometry, size exclusion...
10.1177/1934578x221086989
article
EN
cc-by-nc
Natural Product Communications
2022-03-01
Coming Soon ...